Effects of two-year treatment with the cholinesterase inhibitor rivastigmine on behavioural symptoms in Alzheimer's disease. - Rösler,M.; Retz,W.; Retz-Junginger,P.; Dennler,H.J. (Behav Neurol, 1998)